通过导管更换米特拉的EVOQUE Eos系统的设备配置:简要的叙述审查
Michail Penteris1, Konstantinos Lampropoulos2,3
1Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Expert review of medical devices
|September 11, 2025
概括
EVOQUE Eos系统为其他手术不适合的严重腹患者提供了一种新的跨导管 mitra 置换 (TMVR) 选项. 对于这种完全可检索的设备,早期的结果是有希望的.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗器械技术 医疗器械技术
背景情况:
- 严重的额叶吐 (MR) 带来了重大治疗挑战,特别是在高风险的手术患者身上.
- 过导管 mitra 置换 (TMVR) 是这些患者的一个新兴的替代方案.
- 现有的TMVR系统在安全性,解剖学适合性和程序控制方面存在局限性.
研究的目的:
- 审查EVOQUE EosTMVR系统的设计,程序方面和早期临床结果.
- 将EVOQUE Eos系统与其他当代TMVR设备进行比较.
- 讨论TMVR的潜在挑战和未来方向.
主要方法:
- 对EVOQUE Eos系统的首次人体数据的审查.
- 对正在进行的MISCEND试验数据的分析.
- 与其他TMVR系统进行比较评估.
主要成果:
- EVOQUE Eos系统提供完全皮肤穿透的访问,直观的部署和可检索性.
- 初步研究的早期临床性能数据令人鼓舞.
- 关键的程序性挑战包括对膜泄漏,LVOT阻塞,出血和HALT.
结论:
- EVOQUE Eos系统代表了TMVR技术的重大进步.
- 需要进一步的研究来优化患者选择和抗血栓策略.
- 这个系统有可能改变严重MR的管理.
相关概念视频
Mitral Valve Prolapse I: Introduction
393
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
393
Mitral Valve Prolapse II: Assessment and Management
445
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
445
Mitral Regurgitation I: Introduction
424
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
424
Mitral Stenosis I: Introduction
485
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
485
Mitral Regurgitation III: Medical Management
284
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284
Cardiac Catheterization III: Left Heart Catheterization
597
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
597


